These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 34771518)

  • 1. Epithelial-to-Mesenchymal Transition-Derived Heterogeneity in Head and Neck Squamous Cell Carcinomas.
    Baumeister P; Zhou J; Canis M; Gires O
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLUG-related partial epithelial-to-mesenchymal transition is a transcriptomic prognosticator of head and neck cancer survival.
    Schinke H; Pan M; Akyol M; Zhou J; Shi E; Kranz G; Libl D; Quadt T; Simon F; Canis M; Baumeister P; Gires O
    Mol Oncol; 2022 Jan; 16(2):347-367. PubMed ID: 34382739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer.
    Puram SV; Tirosh I; Parikh AS; Patel AP; Yizhak K; Gillespie S; Rodman C; Luo CL; Mroz EA; Emerick KS; Deschler DG; Varvares MA; Mylvaganam R; Rozenblatt-Rosen O; Rocco JW; Faquin WC; Lin DT; Regev A; Bernstein BE
    Cell; 2017 Dec; 171(7):1611-1624.e24. PubMed ID: 29198524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
    St John MA
    Laryngoscope; 2015 Mar; 125 Suppl 3():S1-11. PubMed ID: 25646683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shooting at Moving and Hidden Targets-Tumour Cell Plasticity and the Notch Signalling Pathway in Head and Neck Squamous Cell Carcinomas.
    Kałafut J; Czerwonka A; Anameriç A; Przybyszewska-Podstawka A; Misiorek JO; Rivero-Müller A; Nees M
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).
    Wintergerst L; Selmansberger M; Maihoefer C; Schüttrumpf L; Walch A; Wilke C; Pitea A; Woischke C; Baumeister P; Kirchner T; Belka C; Ganswindt U; Zitzelsberger H; Unger K; Hess J
    Mol Oncol; 2018 Dec; 12(12):2085-2101. PubMed ID: 30259648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC).
    Pectasides E; Rampias T; Sasaki C; Perisanidis C; Kouloulias V; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
    PLoS One; 2014; 9(4):e94273. PubMed ID: 24722213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
    Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
    Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapy.
    van der Heijden M; Essers PBM; Verhagen CVM; Willems SM; Sanders J; de Roest RH; Vossen DM; Leemans CR; Verheij M; Brakenhoff RH; van den Brekel MWM; Vens C
    Radiother Oncol; 2020 Jun; 147():186-194. PubMed ID: 32413532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of Head and Neck Squamous Cell Carcinoma Stem Cells.
    Qian X; Nie X; Wollenberg B; Sudhoff H; Kaufmann AM; Albers AE
    Adv Exp Med Biol; 2019; 1139():23-40. PubMed ID: 31134493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial-mesenchymal transition gene signature is associated with prognosis and tumor microenvironment in head and neck squamous cell carcinoma.
    Jung AR; Jung CH; Noh JK; Lee YC; Eun YG
    Sci Rep; 2020 Feb; 10(1):3652. PubMed ID: 32107458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delta-crystallin enhancer binding factor 1 controls the epithelial to mesenchymal transition phenotype and resistance to the epidermal growth factor receptor inhibitor erlotinib in human head and neck squamous cell carcinoma lines.
    Haddad Y; Choi W; McConkey DJ
    Clin Cancer Res; 2009 Jan; 15(2):532-42. PubMed ID: 19147758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased SMAD4 expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma.
    Cheng H; Fertig EJ; Ozawa H; Hatakeyama H; Howard JD; Perez J; Considine M; Thakar M; Ranaweera R; Krigsfeld G; Chung CH
    Cancer Biol Ther; 2015; 16(8):1252-8. PubMed ID: 26046389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.
    Obayashi M; Yoshida M; Tsunematsu T; Ogawa I; Sasahira T; Kuniyasu H; Imoto I; Abiko Y; Xu D; Fukunaga S; Tahara H; Kudo Y; Nagao T; Takata T
    Oncotarget; 2016 Feb; 7(7):8223-39. PubMed ID: 26882562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
    Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic and single-cell characterization of patient-derived tumor organoid models of head and neck squamous cell carcinoma.
    Um JH; Zheng Y; Mao Q; Nam C; Zhao H; Koh YW; Shin SJ; Park YM; Lin DC
    bioRxiv; 2024 Jul; ():. PubMed ID: 39005427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia Mediates Differential Response to Anti-EGFR Therapy in HNSCC Cells.
    Wiechec E; Hansson KT; Alexandersson L; Jönsson JI; Roberg K
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28468237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target.
    Rasanen K; Sriswasdi S; Valiga A; Tang HY; Zhang G; Perego M; Somasundaram R; Li L; Speicher K; Klein-Szanto AJ; Basu D; Rustgi AK; Speicher DW; Herlyn M
    Mol Cell Proteomics; 2013 Dec; 12(12):3778-92. PubMed ID: 24037664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
    Schrader CH; Kolb M; Zaoui K; Flechtenmacher C; Grabe N; Weber KJ; Hielscher T; Plinkert PK; Hess J
    Mol Cancer; 2015 May; 14():107. PubMed ID: 25990935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSC-3436 inhibits TWIST-induced epithelial-mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma.
    Lai YJ; Yu WN; Kuo SC; Ho CT; Hung CM; Way TD; Chen CT
    J Cell Physiol; 2019 Jun; 234(6):9118-9129. PubMed ID: 30341909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.